Refined interview technique can reveal plans of terror

February 24, 2016

An interview technique for eliciting intelligence without asking questions has in a series of experiments proven to work very well. The idea dates back to the renowned WWII interrogator Hanns Scharff, but has now -- for the first time -- been empirically validated. The technique can help intelligence agencies reveal plans of future terrorist acts. This is the conclusion drawn in a new dissertation from the University of Gothenburg.

The idea behind the interview technique was developed by Hanns Scharff -- an iconic role model for interrogators worldwide. As an employee of the German Luftwaffe, Scharff became known for an interview style that was based on treating the prisoners with respect and kindness instead of pressuring them with questions and threats of violence.

Instead of an interrogation, Scharff arranged his meeting as a conversation, emphasizing that the most important details were already known, and that all he wanted was help to fill in some minor gaps. This meant that prisoners never knew when they disclosed information that Scharff did not already know, and often ended up revealing much more information than they thought they did.

In Simon Oleszkiewicz's dissertation, Scharff's interview style has been conceptualized as a complete technique that has been experimentally evaluated. The conceptualization includes tactics with respect to storytelling and presenting claims, while avoiding asking explicit questions. The conclusion is that the technique works very well during interviews with persons who are semi-willing to share information.

Those interviewed with the Scharff technique disclosed more information than those who faced explicit questions, Oleszkiewicz says. At the same time, they themselves thought that they were not disclosing much information.

When interviewers avoid direct questions and instead emphasize what they already know, it becomes difficult for the interviewee to cooperate without contributing with new information, and difficult to assess how much one has revealed.

Previously, Scharff's success has been ascribed to his personality. However, in Oleszkiewicz's thesis Scharff's different tactics has been conceptualized into a technique that can be taught to practitioners and may help improve current practices. The technique can be useful for intelligence agencies who attempt to reveal terror plans.

Facts

The dissertation introduced a new experimental scenario where an interviewer held incomplete information about an upcoming fictional terrorist attack. The interviewer was contacted by an informant (a participant in the study) who had enough knowledge to fill some, but not all, of the interviewer's gaps. The informant had some motivation to reveal information to the interviewer, but was also motivated to withhold details. Half of the informants were interviewed with the Scharff technique and the other half by a combination of open-ended and direct questions (the so called direct approach). In total, over 380 participants were interviewed.

Two of the three studies that constitute the dissertation have been financed by the US High-Value Detainee Interrogation Group (HIG) contract J-FBI-12-187. HIG has reviewed the application and awarded the grants, but has not had any involvement in the project design or its implementation. The experimental setup has been ethically reviewed in both Washington and Gothenburg, and all findings have been published in open peer-reviewed journals.
-end-
More information

Dissertation title: Eliciting human intelligence: A conceptualization and empirical testing of the Scharff technique.

Find more information about the dissertation here: http://hdl.handle.net/2077/41567

Contact:

Simon Moberg Oleszkiewicz
telephone: 46-31-786-4270, 46-763-362285
e-mail: simon.oleszkiewicz@psy.gu.se

University of Gothenburg

Related Conclusion Articles from Brightsurf:

Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability
Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability 27.02.2020 The tests assign different women to the group 'low risk of recurrence.' It thus remains unclear who could omit chemotherapy.

Clown fish survival depends on environment more than genetics
Clown fish are unable to genetically adapt to changes in their environment.

'Spin' found in over half of clinical trial abstracts published in top psychiatry journals
'Spin' -- exaggerating the clinical significance of a particular treatment without the statistics to back it up -- is apparent in more than half of clinical trial abstracts published in top psychology and psychiatry journals, finds a review of relevant research in BMJ Evidence Based Medicine.

Micro-ribonucleic acid in milk:Health risk very unlikely
Ribonucleic acid (RNA) occurs in animal and plant cells and has many biological functions.

People's motivations bias how they gather information
A new study suggests people stop gathering evidence earlier when the data supports their desired conclusion than when it supports the conclusion they wish was false.

Negative pressure wound therapy: manufacturer data provided later allow benefit conclusion
Hint and indication of benefit for primary and secondary wound healing, respectively.

A sobering conclusion: Adult hearts contain no stem cells
A detailed cell-by-cell map of all dividing cells in the adult murine heart before and after myocardial infarction was created using advanced molecular and genetic technologies in a combined research effort led by Hans Clevers from the Hubrecht Institute (Netherlands).

Flaws in industry-funded pesticide evaluation
Academic researchers have examined raw data from a company-funded safety evaluation of the pesticide chlorpyrifos.

The order of response options on online questionnaires impacts respondents' choice
The Order of Response Options on Online Questionnaires Impacts Respondents' Choice.

Early benefit assessments: 220th dossier assessment completed by the turn of the year
A host of dossiers assessed by IQWiG to date have addressed oncology drugs.

Read More: Conclusion News and Conclusion Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.